Skip to main content

Robert Steyer

Articles From This Author

Dating Sites: Best, Worst & Weirdest
MUTUAL FUNDS
ABEVFII

Are Fund Managers Better Than Their Funds?

By Robert Steyer
Apr 20, 2009 4:51 PM EDT
Dating Sites: Best, Worst & Weirdest
STOCKS
BACCGS

Can Regional Brokers Keep Outperforming?

By Robert Steyer
Feb 16, 2009 10:49 AM EST
MELA Sciences Is Doomed
STOCKS
AMGNELNJNJ

Wyeth Deal's Big, but Pfizer Still Needs a Blockbuster

By Robert Steyer
Jan 26, 2009 4:43 PM EST
Lilly Sinks as Cholesterol-Lowering Pill Trial Shut Down
STOCKS
AGNMNTMRX

Cosmetic Surgery Stocks Keep Stiff Upper Lip

By Robert Steyer
Oct 28, 2008 5:05 PM EDT
STOCKS
ABTBSXGE

For Abbott, Diversity Remains Paramount

By Robert Steyer
Aug 21, 2008 1:06 PM EDT
STOCKS
MRKWYE

Legal Questions Still Dogging Wyeth

By Robert Steyer
Jul 21, 2008 12:37 PM EDT
Novartis Commits $500 Million to Russia
STOCKS
ABTBAXJNJ

Baxter International Hiding in Plain Sight

By Robert Steyer
Jul 1, 2008 6:59 AM EDT
Dating Sites: Best, Worst & Weirdest
INVESTING
BRLMYLNVS

Generic-Drug Stocks Still Under the Weather

By Robert Steyer
Jun 5, 2008 1:40 PM EDT
STOCKS
AMGNBDXBSX

Need Defense? Think Medical Supplies

By Robert Steyer
Apr 11, 2008 6:44 AM EDT
Novartis Commits $500 Million to Russia
STOCKS
ABIDNAIVGN

The Real Winners of Drug Experimentation

By Robert Steyer
Apr 3, 2008 6:59 AM EDT
Dating Sites: Best, Worst & Weirdest
INVESTING
CRLCVDICLR

A Safer Way to Play the Drug Sector

By Robert Steyer
Feb 26, 2008 6:16 AM EST
STOCKS
JNJMRKPFE

Schering-Plough's Adjusted Profits Top Estimates

By Robert Steyer
Feb 12, 2008 2:56 PM EST
Lilly Sinks as Cholesterol-Lowering Pill Trial Shut Down
STOCKS
AKZOYJNJMRK

Reasons to Believe in Schering-Plough

By Robert Steyer
Feb 11, 2008 2:05 PM EST
INVESTING
BMYGSKMRK

Big Pharma Moving More Work Offshore

By Robert Steyer
Jan 25, 2008 2:06 PM EST
OPINION

Are IPOs Poised for Another Banner Year?

By Robert Steyer
Jan 21, 2008 11:07 AM EST
INVESTING
BMYGSKJNJ

Big Pharma Considers Kicking the OTC Habit

By Robert Steyer
Dec 18, 2007 6:14 AM EST
PERSONAL FINANCE

Your Guide to Collecting Argillite Carvings

By Robert Steyer
Dec 12, 2007 1:40 PM EST
ESMO Preview: Cancer Stocks to Watch
STOCKS
BIIBMRKNBIX

No Easy Fix for Pfizer

By Robert Steyer
Nov 29, 2007 2:14 PM EST
FDA to Review Amgen Drugs: BioBuzz
STOCKS
BRLMYLNVS

Is Mylan Cheap Yet?

By Robert Steyer
Nov 28, 2007 3:14 PM EST
Dating Sites: Best, Worst & Weirdest
STOCKS
CEPH

Cephalon Still a Stressor

By Robert Steyer
Nov 6, 2007 4:04 PM EST
STOCKS
ALKSLLYNKTR

After Exubera, Uncertainty Reigns

By Robert Steyer
Oct 22, 2007 4:01 PM EDT
Dating Sites: Best, Worst & Weirdest
PERSONAL FINANCE
BIDEBAY

Hot Art From the Arctic

By Robert Steyer
Oct 19, 2007 9:47 AM EDT
Dating Sites: Best, Worst & Weirdest
STOCKS
ARAYOCLSOPTR

Can Good Health Last for Medical IPOs?

By Robert Steyer
Sep 11, 2007 2:20 PM EDT
Dating Sites: Best, Worst & Weirdest
STOCKS
ADLRGSKPOZN

Challenges Persist for Glaxo

By Robert Steyer
Aug 22, 2007 4:43 PM EDT
STOCKS
JNJ

J&J's Risperdal Gets New Uses

By Robert Steyer
Aug 22, 2007 4:35 PM EDT
STOCKS
ALUPFE

Pfizer Finds New CFO

By Robert Steyer
Aug 22, 2007 11:18 AM EDT
STOCKS
MRKNVS

FDA Approves Novartis Osteoporosis Drug

By Robert Steyer
Aug 20, 2007 5:19 PM EDT
STOCKS
GSK

Glaxo Drug Gets Black Box

By Robert Steyer
Aug 14, 2007 5:38 PM EDT
Dating Sites: Best, Worst & Weirdest
STOCKS
JNJLLYVPHM

Wyeth Whacked on Drug Setbacks

By Robert Steyer
Aug 10, 2007 1:49 PM EDT
STOCKS
LLYMNKDNKTR

One Giant Leap for MannKind

By Robert Steyer
Aug 9, 2007 5:48 PM EDT
STOCKS
AZNPG

FDA Reviewing AstraZeneca's Nexium, Prilosec

By Robert Steyer
Aug 9, 2007 2:21 PM EDT
STOCKS
CYPBFRXLLY

Another Setback for Wyeth Drug

By Robert Steyer
Aug 8, 2007 4:27 PM EDT
STOCKS
BRL

Earnings Beat Boosts Barr

By Robert Steyer
Aug 8, 2007 10:35 AM EDT
STOCKS
ONXXPFEWYE

Onyx Shines on Nexavar Sales

By Robert Steyer
Aug 7, 2007 6:27 PM EDT
STOCKS
KG

Profits Slide at King Pharmaceuticals

By Robert Steyer
Aug 7, 2007 1:34 PM EDT
STOCKS
PFE

Pfizer's HIV Drug Gets FDA Nod

By Robert Steyer
Aug 6, 2007 4:00 PM EDT
STOCKS
ALKSJNJ

Alkermes Tops Estimates

By Robert Steyer
Aug 3, 2007 11:43 AM EDT
Dating Sites: Best, Worst & Weirdest
STOCKS
AKZOYSGP

Schering-Plough to Sell Stock

By Robert Steyer
Aug 2, 2007 3:16 PM EDT
Dating Sites: Best, Worst & Weirdest
STOCKS
BRLWPI

Watson Pharma CEO to Retire

By Robert Steyer
Aug 2, 2007 10:41 AM EDT
STOCKS
BMYSNY

Earnings Fall at Sanofi

By Robert Steyer
Aug 1, 2007 4:36 PM EDT
STOCKS
NVSTEVAWYE

Teva Runs Past Estimates

By Robert Steyer
Aug 1, 2007 2:46 PM EDT
STOCKS
CEPH

Cephalon Comes Up Short

By Robert Steyer
Aug 1, 2007 1:30 PM EDT
STOCKS
BIIBELN

Good News for Tysabri

By Robert Steyer
Jul 31, 2007 6:54 PM EDT
STOCKS
WYE

Wyeth Again Defends Pristiq

By Robert Steyer
Jul 31, 2007 6:38 PM EDT
STOCKS
GSK

Experts: Keep Glaxo Drug on the Market

By Robert Steyer
Jul 31, 2007 3:44 PM EDT
STOCKS
AAIMEH

Midwest to Mull Sale

By Robert Steyer
Jul 31, 2007 3:33 PM EDT
STOCKS
JNJMRKPFE

J&J Cutting Jobs

By Robert Steyer
Jul 31, 2007 2:37 PM EDT
INSURANCE
LLYMRKPFE

Time to Buy Drugmaker Stocks?

By Robert Steyer
Jul 31, 2007 6:27 AM EDT
STOCKS
BIIBELN

FDA Questions Tysabri for Crohn's Disease

By Robert Steyer
Jul 27, 2007 2:06 PM EDT
STOCKS
SEPR

Soggy Numbers Crush Sepracor

By Robert Steyer
Jul 27, 2007 1:17 PM EDT